|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Correa P: Gastric cancer: Overview.
Gastroenterol Clin North Am. 42:211–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
González CA, Sala N and Rokkas T: Gastric
cancer: Epidemiologic aspects. Helicobacter. 18 Suppl 1:S34–S38.
2013. View Article : Google Scholar
|
|
4
|
Epplein M, Zheng W, Li H, Peek RM Jr,
Correa P, Gao J, Michel A, Pawlita M, Cai Q, Xiang YB and Shu XO:
Diet, Helicobacter pylori strain-specific infection, and gastric
cancer risk among Chinese men. Nutr Cancer. 66:550–557. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fonseca-Nunes A, Agudo A, Aranda N, Arija
V, Cross AJ, Molina E, Sanchez MJ, Bueno-de-Mesquita HB, Siersema
P, Weiderpass E, et al: Body iron status and gastric cancer risk in
the EURGAST study. Int J Cancer. 137:2904–2914. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jakszyn P, Agudo A, Lujan-Barroso L,
Bueno-de-Mesquita HB, Jenab M, Navarro C, Palli D, Boeing H, Manjer
J, Numans ME, et al: Dietary intake of heme iron and risk of
gastric cancer in the European prospective investigation into
cancer and nutrition study. Int J Cancer. 130:2654–2663. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Noto JM and Peek RM Jr: Micronutrients: A
double-edged sword in microbial-induced gastric carcinogenesis.
Trends Cancer. 1:136–144. 2015. View Article : Google Scholar
|
|
8
|
Kim JL, Lee DH, Na YJ, Kim BR, Jeong YA,
Lee SI, Kang S, Joung SY, Lee SY, Oh SC and Min BW: Iron
chelator-induced apoptosis via the ER stress pathway in gastric
cancer cells. Tumour Biol. 37:9709–9719. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park CH, Valore EV, Waring AJ and Ganz T:
Hepcidin, a urinary antimicrobial peptide synthesized in the liver.
J Biol Chem. 276:7806–7810. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ganz T: Systemic iron homeostasis. Physiol
Rev. 93:1721–1741. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Babitt JL and Lin HY: The molecular
pathogenesis of hereditary hemochromatosis. Semin Liver Dis.
31:280–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang DL, Senecal T, Ghosh MC,
Ollivierre-Wilson H, Tu T and Rouault TA: Hepcidin regulates
ferroportin expression and intracellular iron homeostasis of
erythroblasts. Blood. 118:2868–2877. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Q, Wang L, Ma Y, Wu X, Jin L and Yu
F: Increased hepcidin expression in non-small cell lung cancer
tissue and serum is associated with clinical stage. Thorac Cancer.
5:14–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eisfeld AK, Westerman M, Krahl R, Leiblein
S, Liebert UG, Hehme M, Teupser D, Niederwieser D and Al-Ali HK:
Highly elevated serum hepcidin in patients with acute myeloid
leukemia prior to and after allogeneic hematopoietic cell
transplantation: Does this protect from excessive parenchymal iron
loading? Adv Hematol 2011. 4910582011.
|
|
15
|
Pan X, Lu Y, Cheng X and Wang J: Hepcidin
and ferroportin expression in breast cancer tissue and serum and
their relationship with anemia. Curr Oncol. 23:e24–e26. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miseta A, Nagy J, Nagy T, Poór VS, Fekete
Z and Sipos K: Hepcidin and its potential clinical utility. Cell
Biol Int. 39:1191–1202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kamai T, Tomosugi N, Abe H, Arai K and
Yoshida K: Increased serum hepcidin-25 level and increased tumor
expression of hepcidin mRNA are associated with metastasis of renal
cell carcinoma. BMC Cancer. 9:2702009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang S, Chen Y, Guo W, Yuan L, Zhang D,
Xu Y, Nemeth E, Ganz T and Liu S: Disordered hepcidin-ferroportin
signaling promotes breast cancer growth. Cell Signal. 26:2539–2550.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ganz T and Nemeth E: Hepcidin and iron
homeostasis. Biochim Biophys Acta. 1823:1434–1443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmidt PJ: Regulation of iron metabolism
by hepcidin under conditions of inflammation. J Biol Chem.
290:18975–18983. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kawabata H, Uchiyama T, Sakamoto S, Kanda
J, Oishi S, Fujii N, Tomosugi N, Kadowaki N and Takaori-Kondo A: A
HAMP promoter bioassay system for identifying chemical compounds
that modulate hepcidin expression. Exp Hematol. 43:404–413.e5.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee P, Peng H, Gelbart T, Wang L and
Beutler E: Regulation of hepcidin transcription by interleukin-1
and interleukin-6. Proc Natl Acad Sci USA. 102:pp. 1906–1910. 2005;
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wrighting DM and Andrews NC: Interleukin-6
induces hepcidin expression through STAT3. Blood. 108:3204–3209.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Senol K, Ozkan MB, Vural S and Tez M: The
role of inflammation in gastric cancer. Adv Exp Med Biol.
816:235–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM classification of malignant tumours. Hoboken:
Wiley-Blackwell; 2009
|
|
26
|
Brookes MJ, Boult J, Roberts K, Cooper BT,
Hotchin NA, Matthews G, Iqbal T and Tselepis C: A role for iron in
Wnt signalling. Oncogene. 27:966–975. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gozzelino R and Arosio P: Iron homeostasis
in health and disease. Int J Mol Sci. 17:pii: E1302016. View Article : Google Scholar
|
|
28
|
Torti SV and Torti FM: Iron and cancer:
More ore to be mined. Nat Rev Cancer. 13:342–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xue X, Taylor M, Anderson E, Hao C, Qu A,
Greenson JK, Zimmermann EM, Gonzalez FJ and Shah YM:
Hypoxia-inducible factor-2α activation promotes colorectal cancer
progression by dysregulating iron homeostasis. Cancer Res.
72:2285–2293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ciniselli CM, De Bortoli M, Taverna E,
Varinelli L, Pizzamiglio S, Veneroni S, Bonini C, Orlandi R,
Verderio P and Bongarzone I: Plasma hepcidin in early-stage breast
cancer patients: No relationship with interleukin-6, erythropoietin
and erythroferrone. Expert Rev Proteomics. 12:695–701. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Orlandi R, De Bortoli M, Ciniselli CM,
Vaghi E, Caccia D, Garrisi V, Pizzamiglio S, Veneroni S, Bonini C,
Agresti R, et al: Hepcidin and ferritin blood level as noninvasive
tools for predicting breast cancer. Ann Oncol. 25:352–357. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tesfay L, Clausen KA, Kim JW, Hegde P,
Wang X, Miller LD, Deng Z, Blanchette N, Arvedson T, Miranti CK, et
al: Hepcidin regulation in prostate and its disruption in prostate
cancer. Cancer Res. 75:2254–2263. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Marques O, Porto G, Rema A, Rêma A, Faria
F, Paula A Cruz, Gomez-Lazaro M, Silva P, da Silva B Martins and
Lopes C: Local iron homeostasis in the breast ductal carcinoma
microenvironment. BMC Cancer. 16:1872016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nemeth E, Tuttle MS, Powelson J, Vaughn
MB, Donovan A, Ward DM, Ganz T and Kaplan J: Hepcidin regulates
cellular iron efflux by binding to ferroportin and inducing its
internalization. Science. 306:2090–2093. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pinnix ZK, Miller LD, Wang W, D'Agostino R
Jr, Kute T, Willingham MC, Hatcher H, Tesfay L, Sui G, Di X, et al:
Ferroportin and iron regulation in breast cancer progression and
prognosis. Sci Transl Med. 2:43ra562010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ward DG, Roberts K, Brookes MJ, Joy H,
Martin A, Ismail T, Spychal R, Iqbal T and Tselepis C: Increased
hepcidin expression in colorectal carcinogenesis. World J
Gastroenterol. 14:1339–1345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ruchala P and Nemeth E: The
pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci.
35:155–161. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pietrangelo A, Dierssen U, Valli L, Garuti
C, Rump A, Corradini E, Ernst M, Klein C and Trautwein C: STAT3 is
required for IL-6-gp130-dependent activation of hepcidin in vivo.
Gastroenterology. 132:294–300. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao G, Zhu G, Huang Y, Zheng W, Hua J,
Yang S, Zhuang J and Ye J: IL-6 mediates the signal pathway of
JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis
in gastric cancer. Oncol Rep. 35:1787–1795. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Udali S, Guarini P, Ruzzenente A,
Ferrarini A, Guglielmi A, Lotto V, Tononi P, Pattini P, Moruzzi S,
Campagnaro T, et al: DNA methylation and gene expression profiles
show novel regulatory pathways in hepatocellular carcinoma. Clin
Epigenetics. 7:432015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ock CY, Nam AR, Bang JH, Kim TY, Lee KH,
Han SW, Im SA, Kim TY, Bang YJ and Oh DY: Signature of cytokines
and angiogenic factors (CAFs) defines a clinically distinct
subgroup of gastric cancer. Gastric Cancer. 20:164–174. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fraenkel PG: Understanding anemia of
chronic disease. Hematology Am Soc Hematol Educ Program.
2015:14–18. 2015.PubMed/NCBI
|
|
43
|
Knight K, Wade S and Balducci L:
Prevalence and outcomes of anemia in cancer: A systematic review of
the literature. Am J Med. 116 Suppl 7A:11S–26S. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim A, Rivera S, Shprung D, Limbrick D,
Gabayan V, Nemeth E and Ganz T: Mouse models of anemia of cancer.
PLoS One. 9:e932832014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Park S, Jung CW, Kim K, Kim SJ, Kim WS and
Jang JH: Iron deficient erythropoiesis might play key role in
development of anemia in cancer patients. Oncotarget.
6:42803–42812. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Maccio A, Madeddu C, Gramignano G, Mulas
C, Tanca L, Cherchi MC, Floris C, Omoto I, Barracca A and Ganz T:
The role of inflammation, iron, and nutritional status in
cancer-related anemia: Results of a large, prospective,
observational study. Haematologica. 100:124–132. 2015. View Article : Google Scholar : PubMed/NCBI
|
